Concurrent Oral 7 - Rheumatoid Arthritis: Clinical Aspects [OP48-OP53]: OP48. The Risk of Non-Melanoma Skin Cancer in Patients Receiving Anti-TNF Therapies for Rheumatoid Athritis: Results from the British Society for Rheumatology Biologics Register

Autor:	L. Mercer, Kath D. Watson, Nicola J Goodson, M Lunt, Dpm Symmons, K D Watson, Gabriel S. Panayi, KL Hyrich, M. H. Ma, David Scott, W G Dixon, Fowzia Ibrahim, Louise K. Mercer, K. Morgan, Jonathan L. Marks, Andrew Ustianowski, P. A. Wilson, Z. Fekete, Louise C. Pollard, T. Gibson, Gabrielle H. Kingsley, Tarnya Marshall, D P Symmons, Kimme L. Hyrich, IN Bruce, William G Dixon, Nicola J. Gullick, Helena Edlin, Hoda Mirjafari, Alan Mistlin, Timothy L. Jones, Valentine Charlton-Menys, Jonathan D. Rees, James N. Galloway, S. P. Oakley, Diane Bunn, B. Kirkham
Rok vydání:	2010
Předmět:	medicine.medical_specialty business.industry Melanoma Cancer medicine.disease Rheumatology Infliximab Etanercept Internal medicine Rheumatoid arthritis Immunology medicine Adalimumab Pharmacology (medical) Skin cancer business medicine.drug
Zdroj:	Rheumatology. 49:i21-i23
ISSN:	1462-0332 1462-0324
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b860a1fa2fff80c5ca53cd9e5e1e42e0 https://doi.org/10.1093/rheumatology/keq707 Zobrazit plný text záznamu